Venetoclax
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB11581 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | chronic lymphocytic leukemia/small lymphocytic lymphoma with immunoglobulin heavy chain variable-region gene somatic hypermutation | KG + DL |
| 2 | pregerminal center chronic lymphocytic leukemia/small lymphocytic lymphoma | KG + DL |
| 3 | Hodgkins lymphoma | KG + DL |
| 4 | myeloid leukemia | KG + DL |
| 5 | chronic myelogenous leukemia, BCR-ABL1 positive | KG + DL |
| 6 | Ewing sarcoma | KG + DL |
| 7 | follicular lymphoma | KG + DL |
| 8 | metastatic neoplasm | KG + DL |
| 9 | malignant spiradenoma | KG + DL |
| 10 | acute myeloid leukemia with t(8;21)(q22;q22) translocation | KG + DL |
| 11 | acute myeloid leukemia with CEBPA somatic mutations | KG + DL |
| 12 | acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2) | KG + DL |
| 13 | salivary gland type cancer of the breast | KG + DL |
| 14 | breast papillomatosis | KG + DL |
| 15 | bulbar polio | KG + DL |
| 16 | breast lipoma | KG + DL |
| 17 | diabetic mastopathy | KG + DL |
| 18 | benign neoplasm of male breast | KG + DL |
| 19 | giant adenofibroma of the breast | KG + DL |
| 20 | intraductal breast papillomatosis | KG + DL |
| 21 | benign eccrine breast spiradenoma | KG + DL |
| 22 | infiltrating nipple syringomatous adenoma | KG + DL |
| 23 | subareolar duct papillomatosis | KG + DL |
| 24 | fibroepithelial neoplasm | KG + DL |
| 25 | granular cell tumor | KG + DL |
| 26 | breast cyst | KG + DL |
| 27 | non-proliferative fibrocystic change of the breast | KG + DL |
| 28 | ganglioneuroblastoma (disease) | KG + DL |
| 29 | mantle cell lymphoma | KG + DL |
| 30 | breast leiomyoma | KG + DL |
| 31 | breast myoepitheliosis | KG + DL |
| 32 | fibromatosis, gingival | KG + DL |
| 33 | chronic lymphocytic leukemia/small lymphocytic lymphoma | KG + DL |
| 34 | vertebral anomalies and variable endocrine and T-cell dysfunction | KG + DL |
| 35 | retroperitoneal neoplasm | KG + DL |
| 36 | hamartoma of lung | KG + DL |
| 37 | fibroma of lung | KG + DL |
| 38 | breast neoplasm | KG + DL |
| 39 | lung cancer | KG + DL |
| 40 | lung benign neoplasm | KG + DL |
| 41 | lung hilum carcinoma | KG + DL |
| 42 | inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia | KG + DL |
| 43 | lung germ cell tumor | KG + DL |
| 44 | pulmonary sulcus neoplasm | KG + DL |
| 45 | 5q35 microduplication syndrome | KG + DL |
| 46 | junctional epidermolysis bullosa | KG + DL |
| 47 | polyclonal hypergammaglobulinemia | KG + DL |
| 48 | primary cutaneous T-cell non-Hodgkin lymphoma | KG + DL |
| 49 | acute myeloid leukemia with t(8;16)(p11;p13) translocation | KG + DL |
| 50 | neuroblastoma | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.